SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001390777-15-000030
Filing Date
2015-02-10
Accepted
2015-02-10 11:23:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 pdlbiopharma.txt SC 13G/A 53732
  Complete submission text file 0001390777-15-000030.txt   55482
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Subject) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43256 | Film No.: 15591205
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE WALL STREET, 31ST FLOOR NEW YORK NY 10286
Business Address ONE WALL STREET, 31ST FLOOR NEW YORK NY 10286 212-495-1784
Bank of New York Mellon Corp (Filed by) CIK: 0001390777 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6022 State Commercial Banks